Acetyl simvastatin

Acetyl simvastatin is a synthetic derivative of simvastatin, belonging to the statin class of drugs. It functions by competitively inhibiting the enzyme 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, which is a crucial enzyme in the mevalonate pathway responsible for cholesterol biosynthesis in the liver. By blocking HMG-CoA reductase, Acetyl simvastatin reduces the production of cholesterol and promotes the uptake of low-density lipoprotein (LDL) from the bloodstream, thereby lowering cholesterol levels and potentially reducing the risk of cardiovascular diseases. It has been noted for its effectiveness at lower doses and a low toxicity profile, although it is primarily discussed as a chemical compound, reference standard, or impurity rather than a widely marketed pharmaceutical drug with its own distinct clinical development.

Other names

4'-Acetyl simvastatinSimvastatin acetateSimvastatin EP impurity B(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetyloxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoateAcetyl Simvastatin [USP-RS]